NR3C1 and type 2 diabetes mellitus: Parts of these proteins were therapeutic targets of T2D [30], such as glucocorticoid receptor, peroxisome proliferator‐activated receptor delta, poly(ADP‐ribose) polymerase 1, etc. Numerous targets suggested that AGIs from SBG were involved in various signal pathways.